ENTITY
Pixium Vision Sa

Pixium Vision Sa (PIX FP)

37
Analysis
Health CareFrance
Pixium Vision SA develops retinal implant systems. The Company develops epi-retinal and sub-retinal implant systems to treat patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. Pixium Vision markets its systems throughout Europe.
more
11 Oct 2023 07:10Issuer-paid

Pixium Vision - Safeguard proceedings underway

Pixium Vision announced that safeguard proceedings have been opened by the Commercial Court of Paris. Despite the company’s best efforts in seeking...

Share
12 Aug 2023 07:10Issuer-paid

Pixium Vision - Shareholder loan extends runway

Pixium Vision recently announced that it has received a €3m bridge financing loan from shareholders Sofinnova (€1m) and Bpifrance (€2m), which...

Share
02 May 2023 21:40Issuer-paid

Pixium Vision - Focusing on reaching the PRIMAvera milestone

Having completed the required 38 implantations in late 2022, Pixium Vision’s key upcoming clinical milestone is the primary efficacy data, expected...

Share
31 Mar 2023 22:56Issuer-paid

Pixium Vision - Breakthrough designation provides validation

The US Food and Drug Administration (FDA) has granted Breakthrough Device designation (BDD) to Pixium’s wireless Prima bionic vision system (BVS),...

Share
15 Feb 2023 22:50Issuer-paid

Pixium Vision - End of ESGO arrangement comes as no surprise

Pixium has terminated its convertible note financing arrangement with the European Select Growth Opportunities Fund (ESGO) without any penalties....

Share
x